The evaluation of the clinical effect and safety of stereotactic body radiationtherapy for hepatocellularcarcinoma

The evaluation of the clinical effect and safety of stereotactic body radiationtherapy for hepatocellularcarcinoma - Stereotactic body radiationtherapy for hepatocellularcarcinoma

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000016834

Enrollment

100

Registered

2015-03-18

Start date

2015-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellularcrcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) hypervascular HCC nodules, each up to 50 mm in diameter; (2) not suitable for the hepatic resection or ablative therapy; (3) Child-Turcotte-Pugh (CTP) score<7.CTP) score<7.

Exclusion criteria

Exclusion criteria: neighboring the Intestinal tract

Design outcomes

Primary

Measure	Time frame
efficacy	—

Secondary

Measure	Time frame
efficacy	—

Countries

Japan

Contacts

Public ContactHiroshi Aikata

Hiroshima university hospital Department of Medicine and Molecular Science

aikata@hiroshima-u.ac.jp0822575555

Outcome results